Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ocular Therapeutix (OCUL) Return on Assets (2016 - 2025)

Ocular Therapeutix (OCUL) has 12 years of Return on Assets data on record, last reported at 0.43% in Q4 2025.

  • For Q4 2025, Return on Assets fell 8.0% year-over-year to 0.43%; the TTM value through Dec 2025 reached 0.43%, down 8.0%, while the annual FY2025 figure was 0.42%, 5.0% up from the prior year.
  • Return on Assets reached 0.43% in Q4 2025 per OCUL's latest filing, up from 0.57% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.22% in Q2 2024 and bottomed at 0.71% in Q2 2023.
  • Average Return on Assets over 5 years is 0.44%, with a median of 0.43% recorded in 2025.
  • Peak YoY movement for Return on Assets: soared 88bps in 2021, then fell -30bps in 2025.
  • A 5-year view of Return on Assets shows it stood at 0.4% in 2021, then plummeted by -38bps to 0.55% in 2022, then grew by 21bps to 0.43% in 2023, then rose by 20bps to 0.35% in 2024, then decreased by -24bps to 0.43% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Assets were 0.43% in Q4 2025, 0.57% in Q3 2025, and 0.52% in Q2 2025.